Opertech Bio, a Philadelphia, PA-based provider of taste testing solutions, secured $750k in funding.
The round was led by Gabriel Investments, with participation from management and other investors. In conjunction with the funding, Kevin Kleinschmidt, a partner at Gabriel Investments, joined Opertech’s board of directors.
The company intends to use the funds to complete development and support marketing for its technology.
Led by Scott Horvitz, Chief Executive Officer, and Kyle Palmer, Chief Science Officer, Opertech Bio has developed taste evaluation technology called Microtiter Operant Gustometer, or MOG, an automated high throughput system for rapid characterization of taste sensory properties. It can be used to discover new flavor ingredients, measure palatability and optimize flavor formulations.